These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8807721)

  • 21. [Post-implant antithrombotic treatment after intracoronary stents. Thrombotic occlusion].
    Alonso Martín JJ; Durán Hernández JM; Gimeno de Carlos F; de la Fuente Galán L; Muñoz San José JC; Fernández-Avilés F
    Rev Esp Cardiol; 1997; 50 Suppl 2():31-43. PubMed ID: 9221455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis.
    Fareed J; Ma Q; Florian M; Maddineni J; Iqbal O; Hoppensteadt DA; Bick RL
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():89-104. PubMed ID: 15085470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Old and new natural products as the source of modern antithrombotic drugs.
    Beretz A; Cazenave JP
    Planta Med; 1991 Oct; 57(7):S68-72. PubMed ID: 1956960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute thrombotic disorders.
    Kuntz JG; Cheesman JD; Powers RD
    Am J Emerg Med; 2006 Jul; 24(4):460-7. PubMed ID: 16787806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant drugs: an update.
    Kwaan HC; Samama MM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):511-22. PubMed ID: 15225111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Helping antibodies. Targeted antithrombotic and fibrinolytic therapy].
    Schwarz M; Hagemeyer CE; Peter K; Bode C
    Hamostaseologie; 2007 Dec; 27(5):360-2. PubMed ID: 18060247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antithrombotic agents.
    Castelli R; Porro F; Savo D; Cassinerio E
    Panminerva Med; 2006 Dec; 48(4):247-56. PubMed ID: 17215797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What is new in antithrombotic treatment?].
    Mikdame M; Kharchafi A; Toloune F; Archane MI
    Ann Biol Clin (Paris); 2002; 60(2):131-41. PubMed ID: 11937438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin agents as anticoagulants and antithrombotics: implications in drug development.
    Fareed J; Callas D; Hoppensteadt DA; Lewis BE; Bick RL; Walenga JM
    Semin Hematol; 1999 Jan; 36(1 Suppl 1):42-56. PubMed ID: 9930564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging antithrombotic treatments for acute coronary syndromes.
    Golino P; Ragni M; Cirillo P; Buono C; Piro O; Chiariello M
    Cardiologia; 1999 Nov; 44(11):969-80. PubMed ID: 10686772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
    Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
    Buchanan MR; Brister SJ
    Wien Klin Wochenschr; 1999 Feb; 111(3):81-9. PubMed ID: 10093889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ; Waly HM; Wilson JM
    Eur Heart J; 1998 Apr; 19 Suppl D():D3-9. PubMed ID: 9597517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor Xa inhibitors: today and beyond.
    Walenga JM; Jeske WP; Hoppensteadt D; Fareed J
    Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The promises of new antithrombotic agents].
    Camez A; Levy D
    Rev Prat; 1992 Nov; 42(17):2151-5. PubMed ID: 1290037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antithrombotic drugs: potential for use in oncology.
    Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis and anticoagulation.
    Hirsh J; Weitz JI
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):118-32. PubMed ID: 10595760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.